Silencing Slfn2 prevents the growth of pre-leukemic T cells in T cell acute lymphoblastic leukemia (T-ALL), which is induced by the intracellular domain of NOTCH1 (ICN1) [96] and attenuates the development and the progression of T-ALL in mice [96]. Here, NOTCH1 is linked to acute lymphoblastic leukemia.